Publicaciones en colaboración con investigadores/as de University of Bari Aldo Moro (26)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation

    Cancer Genetics, Vol. 284-285, pp. 5-11

  3. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  4. Features and outcomes of bailout repeat transcatheter aortic valve implantation (TAVI): the Bailout Acute TAVI-in-TAVI to Lessen Events (BATTLE) international registry

    Clinical Research in Cardiology, Vol. 113, Núm. 1, pp. 68-74

  5. Multicentre retrospective analysis on pulmonary metastasectomy: an European perspective

    European Journal of Cardio-thoracic Surgery , Vol. 65, Núm. 4

  6. Zoonotic dirofilariases: one, no one, or more than one parasite

    Trends in Parasitology, Vol. 40, Núm. 3, pp. 257-270

2023

  1. A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions

    Cancer Genetics, Vol. 272-273, pp. 16-22

2021

  1. Erythrocytes and nanoparticles: New therapeutic systems

    Applied Sciences (Switzerland), Vol. 11, Núm. 5, pp. 1-17

  2. Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study

    European Journal of Surgical Oncology, Vol. 47, Núm. 6, pp. 1481-1488

2019

  1. 1q23.1 homozygous deletion and downregulation of Fc receptor-like family genes confer poor prognosis in chronic lymphocytic leukemia

    Clinical and Experimental Medicine, Vol. 19, Núm. 2, pp. 261-267

  2. Clinical and genetic characteristics of late-onset Huntington's disease

    Parkinsonism and Related Disorders, Vol. 61, pp. 101-105

2018

  1. Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study

    American Journal of Gastroenterology, Vol. 113, Núm. 3, pp. 396-403

  2. Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study

    Journal of Huntington's Disease, Vol. 7, Núm. 3, pp. 209-222

  3. Risk factors for unfavourable postoperative outcome in patients with Crohn's disease undergoing right hemicolectomy or ileocaecal resection. An international audit by ESCP and S-ECCO

    Colorectal Disease, Vol. 20, Núm. 3, pp. 219-227

2017

  1. Cognitive decline in Huntington's disease expansion gene carriers

    Cortex, Vol. 95, pp. 51-62

2016

  1. A rare but recurrent t(8;13)(q24;q14) translocation in B-cell chronic lymphocytic leukaemia causing MYC up-regulation and concomitant loss of PVT1, miR-15/16 and DLEU7

    British Journal of Haematology, Vol. 172, Núm. 2, pp. 296-299

  2. Stress physiology of lactic acid bacteria

    Microbiology and Molecular Biology Reviews, Vol. 80, Núm. 3, pp. 837-890

2013

  1. Age and organ damage correlate with poor survival in myeloma patients: Meta-analysis of 1435 individual patient data from 4 randomized trials

    Haematologica, Vol. 98, Núm. 6, pp. 980-987

  2. Suicidal ideation in a European Huntington's disease population

    Journal of Affective Disorders, Vol. 151, Núm. 1, pp. 248-258

  3. The V471A Polymorphism in Autophagy-Related Gene ATG7 Modifies Age at Onset Specifically in Italian Huntington Disease Patients

    PLoS ONE, Vol. 8, Núm. 7